Searchable abstracts of presentations at key conferences in endocrinology

ea0020p484 | Obesity and Metabolism | ECE2009

Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase-1, HDL-paraoxonase and arylestherase activities but affects oxidative stress and inflamation

Tabur Suzan , Nur Torun Ayse , Sabuncu Tevfik , Nuri Turan Mehmet , Riza Ocak Ali , Celik Hakim

Paraoxonase is a high-density lipoprotein-bound antioxidant enzyme that inhibits atherosclerosis. Metabolic syndrome is a combination of several metabolic abnormalities and known to be related with increased cardiovascular events. The most important component of metabolic syndrome which have impact on oxidative stress is diabetes, the most severe form of disturbed carbohydrate metabolism. The effect of metabolic syndrome on oxidative stress and paroxonase-1 (PON-1) activity ha...

ea0014p651 | (1) | ECE2007

Asymmetric dimethylarginine levels and carotid intima media thickness in patients with polycystic ovary syndrome

Pamuk Baris , Kulaksizoglu Mustafa , Nur Torun Ayse , Taner Ertugrul Derun , Ciftci Ozgur , Ozcimen Emel , Uckuyu Ayla , Kulaksizoglu Sevsen , Bayraktar Nilufer , Guvener Demirag Nilgun

Increased plasma concentration of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, has been associated with cardiovasular risk factors. The aim of this study was evaluate plasma ADMA levels and subclinical atherosclerosis in patients with polycystic ovary syndrome (PCOS) and healty controls.Thirty-five patients with PCOS and age, body mass index (BMI) matced thirty-one healty subjects were included in the study.PCOS w...